by Jordana Choucair | Jul 20, 2022 | Life Sciences
Food and Drug Administration (FDA) Commissioner Robert Califf said the nonprofit Reagan-Udall Foundation will team up with outside experts to thoroughly review agency’s food and tobacco programs. Califf’s comments come after the nationwide baby formula shortage...
by Jordana Choucair | Jul 20, 2022 | Opioid/Substance Use Disorders
The Centers for Disease Control and Prevention (CDC) released new data indicating that overdose death rates surged among Black, American Indian, and Alaska Native individuals in 2020. According to the data from 25 states and the District of Columbia, the overdose...
by Jordana Choucair | Jul 20, 2022 | Payers
JPMorgan Chase & Co.’s health care arm plans to invest $30 million in a three-year-old health plan administrator called Centivo, a health plan for self-funded employers. Centivo’s model enables employers to offer benefits that include no deductibles, free...
by Jordana Choucair | Jul 19, 2022 | Health IT
Tech developer Fold Health launched an interoperable digital health tech stack for primary care. The company offers a comprehensive, customizable operating system that can be laid on top of existing EHRs or platforms. The entrepreneurs built the initial...
by Jordana Choucair | Jul 19, 2022 | Life Sciences
House representatives called on the Department of Health and Human Services (HHS) to penalize drugmakers that have lowered or eliminated price breaks through the federal 340B Drug Discount program. In a letter, the group of 181 lawmakers said, “vulnerable...
by Jordana Choucair | Jul 19, 2022 | Life Sciences
Independent advisers to the Centers for Disease Control and Prevention (CDC) will meet today to discuss Novavax Inc.’s protein-based COVID-19 vaccine. The Food and Drug Administration last week authorized it as a primary immunization for adults, but has not yet...
Recent Comments